Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial
达普司他每周三次给药与传统促红素治疗血液透析患者贫血的疗效比较:ASCEND-TD:一项3期随机、双盲、非劣效性试验
期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.00550122
Coyne, Daniel W; Singh, Ajay K; Lopes, Renato D; Bailey, Christine K; DiMino, Tara L; Huang, Chun; Connaire, Jeffrey; Rastogi, Anjay; Kim, Sung-Gyun; Orias, Marcelo; Shah, Sapna; Patel, Vickas; Cobitz, Alexander R; Wanner, Christoph